References
- Aida, Y., et al., 2011. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. International journal of medical sciences, 8 (6), 470.
- Baker, J.E., et al., 2007. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. Journal of molecular and cellular cardiology, 43 (4), 437–444.
- Balmes, J., et al., 2003. American Thoracic Society statement: occupational contribution to the burden of airway disease. American journal of respiratory and critical care medicine, 167 (5), 787–797.
- Bartziokas, K., et al., 2014. Serum uric acid as a predictor of mortality and future exacerbations of COPD. The european respiratory journal, 43 (1), 43–53.
- Chen, L., et al., 2010. Cigarette smoke enhances β-defensin 2 expression in rat airways via nuclear factor-κB activation. European respiratory journal, 36 (3), 638–645.
- Ciencewicki, J., Trivedi, S., and Kleeberger, S.R., 2008. Oxidants and the pathogenesis of lung diseases. The journal of allergy and clinical immunology, 122 (3), 456–468.
- Cristovao, C., et al., 2013. Evaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary disease. Revista portuguesa de pneumologia, 19 (2), 70–75.
- Daga, M.K., et al., 2003. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. Journal of biosciences, 28 (1), 7–11.
- Demedts, I.K., et al., 2006. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax, 61 (3), 196–201.
- Dozor, A.J., 2010. The role of oxidative stress in the pathogenesis and treatment of asthma. Annals of the new york academy of sciences, 1203, 133–137.
- Garcia-Pachon, E., Padilla-Navas, I., and Shum, C., 2007. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung, 185 (1), 21–24.
- Gosker, H.R., et al., 2005. Altered antioxidant status in peripheral skeletal muscle of patients with COPD. Respiratory medicine, 99 (1), 118–125.
- Gurgun, A., et al., 2013. Effects of nutritional supplementation combined with conventional pulmonary rehabilitation in muscle-wasted chronic obstructive pulmonary disease: a prospective, randomized and controlled study. Respirology, 18 (3), 495–500.
- Halbert, R.J., et al., 2006. Global burden of COPD: systematic review and meta-analysis. The european respiratory journal, 28 (3), 523–532.
- Haq, I., et al., 2011. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD. Thorax, 66 (11), 970–976.
- Heffner, J.E. and Repine, J.E., 1989. Pulmonary strategies of antioxidant defense. The american review of respiratory disease, 140 (2), 531–554.
- Hendrix, A.Y. and Kheradmand, F., 2017. The role of matrix metalloproteinases in development, repair, and destruction of the Lungs. Progress in molecular biology and translational science, 148, 1–29.
- Housley, D.G., et al., 1995. Depletion of urate in human nasal lavage following in vitro ozone exposure. The international journal of biochemistry & cell biology, 27 (11), 1153–1159.
- Hunninghake, G.M., et al., 2009. MMP12, lung function, and COPD in high-risk populations. The new england journal of medicine, 361 (27), 2599–2608.
- Hunninghake, G.W., et al., 1981. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science, 212 (4497), 925–927.
- Jialal, I., Vega, G.L., and Grundy, S.M., 1990. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis, 82 (3), 185–191.
- Kim, D.O., et al., 2002. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. Journal of agricultural and food chemistry, 50 (13), 3713–3717.
- Kirkil, G., et al., 2008. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease. Respiratory medicine, 102 (6), 840–844.
- Kodama, Y., et al., 2015. Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease (COPD), asthma-COPD overlap syndrome, and bronchial asthma. The Clinical respiratory Journal. doi: 10.1111/crj.12436 [Accessed 9th Oct 2017].
- Lin, L., Chun, W., and Fuqiang, W., 2014. An unexpected role for serum uric acid as a biomarker for severity of asthma exacerbation. Asian pacific journal of allergy and immunology, 32 (1), 93.
- Maurya, P.K., Kumar, P., and Chandra, P., 2016a. Age-dependent detection of erythrocytes glucose-6-phosphate dehydrogenase and its correlation with oxidative stress. Archives of physiology and biochemistry, 122, 61–66.
- Maurya, P.K., et al., 2016b. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 65, 134–144.
- Morrow, J.D., et al., 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers—smoking as a cause of oxidative damage. New england journal of medicine, 332 (18), 1198–1203.
- Negre-Salvayre, A., et al., 2008. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. British journal of pharmacology, 153 (1), 6–20.
- Niewoehner, D.E., Kleinerman, J., and Rice, D.B., 1974. Pathologic changes in the peripheral airways of young cigarette smokers. The new england journal of medicine, 291 (15), 755–758.
- Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95 (2), 351–358.
- Padayatty, S.J., and Levine, M., 2016. Vitamin C: the known and the unknown and Goldilocks. Oral diseases, 22 (6), 463–493.
- Pawar, M.R.S. and Abhang, S.A., 2017. Consumption of GSH with the increase in oxidative stress in chronic obstructive pulmonary disease (COPD) patients. International journal of current research and review, 9, 25–29.
- Pietri, S., et al., 1994. Ascorbyl free radical: a noninvasive marker of oxidative stress in human open-heart surgery. Free radical biology & medicine, 16 (4), 523–528.
- Pirabbasi, E., et al., 2016. Efficacy of ascorbic acid (vitamin C) and/N-acetylcysteine (NAC) supplementation on nutritional and antioxidant status of male chronic obstructive pulmonary disease (COPD) patients. Journal of nutritional science and vitaminology, 62 (1), 54–61.
- Pryor, W.A. and Stone, K., 1993. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Annals of the new york academy of sciences, 686, 12–27.
- Rahman, I., 2005. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treatments in respiratory medicine, 4 (3), 175–200.
- Rizvi, S.I. and Maurya, P.K., 2007. Markers of oxidative stress in erythrocytes during aging in humans. Annals of the new york academy of sciences, 1100, 373–382.
- Sautin, Y.Y. and Johnson, R.J., 2008. Uric acid: the oxidant-antioxidant paradox. Nucleosides, nucleotides & nucleic acids, 27 (6), 608–619.
- Ståhl, E., et al., 2005. Health-related quality of life is related to COPD disease severity. Health and quality of life outcomes, 3, 56.
- Torres-Ramos, Y.D., et al., 2009. Correlation of plasma protein carbonyls and C-reactive protein with GOLD stage progression in COPD patients. The open respiratory medicine journal, 3, 61–66.
- Tsiligianni, I.G. and van der Molen, T., 2010. A systematic review of the role of vitamin insufficiencies and supplementation in COPD. Respiratory research, 11, 171.
- van der Vliet, A., et al., 1999. Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. The american journal of physiology, 276 (2 Pt 1), L289–L296.
- Vogelmeier, C.F., et al., 2017. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology, 22 (3), 575–601.